Palladiem’s Halozyme HALO Stock Holding History

Palladiem’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$114K	Sell	1,455 -285	-16%	-$19.4K	0.11%	80
2026 Q1	$117K	Hold	1,740	–	–	0.11%	68
2025 Q4	$118K	Buy	+1,740	New	+$117K	0.11%	69

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Palladiem's HALO Position: Q2 2026 in Review

Palladiem reduced its Halozyme (HALO) stake by 16% in Q2 2026, selling an estimated $19.4K and leaving 1,455 shares worth $114K. The position accounts for 0.11% of the portfolio, ranked #80.

Palladiem first reported a position in HALO in Q4 2025 and has held it in 3 quarters since. The position peaked at $118K in Q4 2025. 668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

Palladiem held 1,455 shares of Halozyme worth $114K as of Q2 2026.
Palladiem sold 285 Halozyme shares in Q2 2026, an estimated $19.4K.
Halozyme made up 0.11% of Palladiem's portfolio in Q2 2026, its #80 holding.
Palladiem first reported a position in Halozyme in Q4 2025 and has held it in 3 quarters since.
Palladiem's Halozyme position peaked at $118K in Q4 2025.
668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Palladiem's 13F filing for Q2 2026, filed 13 Aug 2026.